New Alliance Capital co-led Eccogene’s Series B round, while Zhongguancun Science Park led Emposat’s pre-Series B round. Also, UDS secured nearly $21 million in an extended Series A round.
Eccogene raises $25m Series B round
Eccogene, a biopharmaceutical firm developing innovative therapeutic solutions for metabolic diseases, has bagged 180 million yuan ($25 million) in a Series B financing round.
Local investment firm New Alliance Capital, which invests in healthcare, cleantech, technology, media, and telecom (TMT), co-led the funding round with healthcare-focused Zhangjiang Healthcare Venture Capital.
The round, participated by Rockbleu Capital, YuFu Investment, Huajin Capital, and Elikon Venture, will be used to support the development of Eccogene’s clinical-stage pipeline and to accelerate its preclinical programmes for metabolic and immunological diseases, according to a company release on June 12.
Existing investors including Delos Capital, Oriza Seed Capital, and Qingsong Capital, also re-upped.
UDS secures nearly $21m in Series A
Chinese industrial software developer UDS has snagged 150 million yuan ($20.9 million) in an extended Series A round, according to a company announcement on June 6.
The round saw the participation of state-affiliated investors including Shanghai Zhangjiang Science and Technology Investment, and Shanghai STVC Group. Guozhu Capital, Yinhe Yuanhui Investment, Qcapital, and Zheling Investment are among the other participating investors, per the release.
The firm will use the proceeds to accelerate R&D and expand its national sales network.
Shang Qi Capital, the private equity (PE) arm of China’s state-owned automobile giant SAIC Motor, and Zheling Investment also participated in the round, per the report.
Emposat bags $28m in pre-Series B round
Chinese commercial space firm Emposat has raised 200 million yuan ($28 million) in a pre-Series B financing round led by Zhongguancun Science Park, dubbed as the Silicon Valley of Beijing.
The round saw the participation of local investors including Huge Capital, Jinshajiang Hongyu Capital, Taicanggang Hongrun Private Equity Fund Management, Ultra Buttonwood Capital, and Jundu Investment, according to a company release.
The firm will leverage the funding to level up the ground station facilities, as well as in the R&D of the ground system.
